Skip to main content
Log in

Prolonged-release buprenorphine for OUD in prisons reduces costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. Camurus AB provided funds for the study.

Reference

  • Wright N, et al. OUD Care Service Improvement with Prolonged-release Buprenorphine in Prisons: Cost Estimation Analysis. ClinicoEconomics and Outcomes Research : 9 Sep 2020. Available from: URL: https://doi.org/10.2147/CEOR.S256714

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Prolonged-release buprenorphine for OUD in prisons reduces costs. PharmacoEcon Outcomes News 862, 24 (2020). https://doi.org/10.1007/s40274-020-7142-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7142-5

Navigation